Risk factors for poor outcome of fungal peritonitis in Chinese patients on continuous ambulatory peritoneal dialysis

Peritoneal Dialysis International

Volumn 23, Issue SUPPL. 2, 2003, Pages

  Lo, Stanley H K ^a   Chan, Ching Kit ^a   Shum, Hoi Ping ^a   Chow, Vincent C C ^a   Mo, Ka Leung ^a   Wong, Kin Shing ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Continuous ambulatory peritoneal dialysis; Fungal peritonitis; Risk factors

Indexed keywords

FLUCONAZOLE; FLUCYTOSINE; GLUCOSE; PERITONEAL DIALYSIS FLUID;

ADULT; AGED; ARTICLE; BACTERIAL PERITONITIS; CANDIDA PARAPSILOSIS; CHINESE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; FUNGUS IDENTIFICATION; HEMODIALYSIS PATIENT; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; KIDNEY FAILURE; MALE; MORTALITY; MULTIVARIATE ANALYSIS; MYCOSIS; NONHUMAN; OUTCOMES RESEARCH; PATHOGENESIS; PERITONEAL FLUID; PERITONITIS; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEX RATIO;

EID: 0347135851     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080302302s25     Document Type: Article

References (10)

1. Wang AY, Yu AW, Li PK, Lam PK, Leung CB, Lai KN, et al. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single centre. Am J Kidney Dis 2000; 36:1183-92.
2. Chan TM, Chan CY, Cheng SW, Lo WK, Lo CY, Cheng IK. Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients. Nephrol Dial Transplant 1994; 9:539-42.
3. Huang JW, Hung KY, Wu KD, Peng YS, Tsai TJ, Hsieh BS. Clinical features of and risk factors for fungal peritonitis in peritoneal dialysis patients. J Formos Med Assoc 2000; 99:544-8.
4. Lo WK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28:549-52.
5. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 2000; 20:396-411.
6. Bren A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1998; 17:839-43.
7. Wong PN, Mak SK, Lo KY, Tong GM, Wong AK. A retrospective study of seven cases of Candida parapsilosis peritonitis in CAPD patients: the therapeutic implications. Perit Dial Int 2000; 20:76-9.
8. Kaitwatcharachai C. Candida parapsilosis peritonitis in patients on CAPD. Mycopathologia 2002; 154:181-4.
9. Dahl NV, Foote EF, Searson KM, Fein JL, Kapoian T, Steward CA, et al. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis. Ann Pharmacother 1998; 32:1284-9.
10. Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant 1998; 13:154-9.